CtNHase Mutants for Dynamic Kinetic Resolution of Nitriles
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing Levetiracetam and related lactams suffer from low yields and lack of (S)-selective nitrile hydratases capable of utilizing 2-(2-pyrrolidin-1-yl)-butanenitrile, with existing enzymes showing limited enantioselectivity and stability.
Innovation Solution
Development of a biocatalytic process using (S)-nitrile hydratase enzymes, specifically CtNHase, which undergoes dynamic kinetic resolution to achieve higher yields of (S)-2-(pyrrolidine-1-yl)butaneamide through racemization of the substrate, and subsequent mutation of CtNHase to enhance enantioselectivity and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If classical enzymatic kinetic resolution is used, then enantioselectivity is achieved, but the yield is limited to maximum 50%
Solution Approach 1:
The patent applies dynamic kinetic resolution by introducing a racemization step that converts the unreacted (R)-enantiomer back to the (S)-enantiomer, creating a dynamic equilibrium that allows continuous conversion to product. This transforms the static 50% yield limitation into a dynamic process achieving up to 99.8% yield while maintaining enantioselectivity through the enzyme's preference for (S)-substrate
Solution Approach 2:
The patent implements continuous conversion by coupling the enzymatic resolution step with a racemization step. The enzyme continuously converts (S)-substrate to product while the racemization step continuously replenishes (S)-substrate from (R)-substrate, creating a continuous useful action that overcomes the traditional batch resolution limitation
2Manufacturing precision
If existing NHase enzymes are used, then nitrile hydration is catalyzed, but enantioselectivity and stability are limited
Solution Approach 1:
The patent employs directed evolution and site-directed mutagenesis to change the amino acid sequence parameters of CtNHase, specifically mutating residues in the substrate binding pocket (e.g., F51L, F167Y, H146L mutations). These parameter changes in the enzyme structure improve both enantioselectivity for (S)-substrate and operational stability without losing catalytic activity
Solution Approach 2:
The patent replaces the natural enzyme with an engineered enzyme variant that has optimized properties. Through rational design and directed evolution, the natural CtNHase is substituted with improved mutants that have enhanced enantioselectivity and stability, effectively replacing the mechanical/biological system with an optimized version
3Productivity
If racemization is introduced to improve yield, then dynamic kinetic resolution is achieved, but process complexity increases
Solution Approach 1:
The patent merges the enzymatic hydration reaction and the chemical racemization step into a single integrated process. The enzyme catalyst and racemization conditions are combined in one reaction vessel, allowing simultaneous occurrence of both steps without requiring separate unit operations, thus reducing overall process complexity despite adding functionality
Solution Approach 2:
The patent uses the enzyme itself as an intermediary that facilitates the dynamic kinetic resolution. The enzyme acts as a mediator that preferentially binds and converts (S)-substrate while allowing (R)-substrate to racemize, creating a self-regulating system where the enzyme's selectivity drives the entire process without requiring complex external control mechanisms
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves yields above 50% and enantiomeric excess of up to 99.8%, significantly improving the production efficiency and selectivity of (S)-Levetiracetam and related compounds.
Implementation Method 1
Nitrile hydratases (NHase; EC 4.2.1.84) catalyze the hydration of nitriles to the corresponding amides
Implementation Method 2
which undergoes dynamic kinetic resolution to achieve higher yields of (S)-2-(pyrrolidine-1-yl)butaneamide through racemization of the substrate
Data Source
AI summary
The present invention relates to a novel biocatalytic process for the stereoselective preparation of alpha amino amide compounds catalyzed by NHase enzymes. A further aspect of the invention relates to novel NHase enzymes as well as further improved NHase enzyme mutants, nucleic acid molecules encoding these enzymes, recombinant microorganisms suitable for preparing such enzymes and mutants. Another aspect of the invention relates to a chemo-biocatalytic process for the preparation of lactam compounds comprising the new catalytic process for the preparation of alpha amino amide compounds catalyzed by NHase enzymes, as well as the chemical oxidation of the alpha amino amide by applying certain chemical oxidation catalysts suitable for converting the alpha amino amide under retention of its stereochemical configuration to the respective lactam. The novel chemo-biocatalytic process is particularly suited for the synthesis of valuable pharmaceutical compounds, like in particular (S)-Levetiracetam.